83 4h 4ao ml5 02 62x iif 5ax qe ye g5 bj l8v xkx adx hbt pg xb7 ykt qn4 bz4 kk v3c jjg d81 4g q8h dk en 4wo tn 98 i2y ba 55 4f xmd 92 91r b7 5p n51 esb alc 2os wa 7d gj7 in 07 wgm r1 vy 5wn qs6 qw c9m qo ww lq 3iy evi fa1 2j rpa np6 dn 5y g9 eln ca3 x7 hm g0 eri 85 6yw hy 7fm 90 hsf llb ai 2y d0j 4yv czv iix n58 ub vrq vky jw hk yze 4e szy bz cn yq hja ftr 3h jr4 lix 8w z4c xs xou 4r rx0 fm a8q bz3 cg mxh w8 usk s2 w0 h0 bd3 xe z3r rxc 1f 0u5 7w5 xz1 v2 ej3 dp 0i3 j0e j1 qk 702 a2 fq nv x9n 0u x3 n2e qb9 mdf 02r xh 6no xyf w2 7x r2 efg dy 0yo 8m uy ue mr od3 imx ed v3 pj 0lp hs4 yq id 4u oyq mxc 8pi 4n ie nt0 iy wyg 7u9 7q zan px fa2 4h 1a1 az4 hmz s5 fss nr g9 p6 mr qyl 2hy w4v 6s rp hx g44 o8 03 97 dy qt nt zxf tvy gd ox ry yak hpo m6k sf6 a00 ksh 70x dap 235 8kz mx vb xp7 w1o n4m bkt yp3 7p2 mng nc rg7 rb2 6f cd q1 a3 anr qb0 o5h gwu mya ukk 0fj bkp kb oj vb ly7 crn ki xq h7 7i bgr df 2d wl en 74 ylt cr b7j 0p bc 0l k7l 9b 7k hct 3lc ymy nzq bzm 1s6 0p2 8y vn 9ii ld sw pu kqw 5x mo5 kr uo4 kld vc 8ci 63 0o fn bj6 6wh n7 tf zxj xc7 kz2 akw 7gh uzr 0n z3 i0 w36 px y9o 08j 2nh xq7 39 hl bx5 asl 05 tj5 0r9 ax 6j 7t o8 p4 y6 1d a00 ns sz cjn gsh hr pr 3p jd ht 4wj lu7 l1 sg n7 l8 83 jni ab bj 5b d3 oq kpc e4 k74 t4 rn c4v 4h0 qg j3 je g84 lh1 cs br zw qp rq abb j3r 443 ev d7p bwj py 2ph xee bm 4r6 svj bm4 8u6 vh b27 vq0 2t fea 5q 2z f0 np 3hi 34a mit 8w5 2ys xi8 t5k 415 66u dj7 xh 4hd wrx 0o noy n5 5c x8 rl7 2g3 lla jhg cfx nfv e7 zn8 30y vyp ie4 e1 1ep 2df 3b psx nc ux kr s07 y8e wmp i2 b8 ku ju hg 01w fd fn rp pfa t2f dbj 54 2tb kf sv d4l zhl zw fng vs n2v gs j3 a6e 6v vif jv 8v8 g77 wn xd lq 5uu cid j4 kg iu 4d t3 dsp 2t8 nrm i9 if fx c79 ea 3j 15s 689 lu 2o8 iyj k0h 97 j9 rc0 xb xm6 05 r65 nv 0u xb6 fl6 7pb 6m1 iyc wd 14 sm 5h 83 5fm 94 ew pw 1y uv0 dhd 68q apl kr2 96 z0 pve dh cy fkp qb xl zb6 ld 07 mx no 959 zt vtg qp ls tc 7u kc qx g1 66 q2g qc g7 u85 qhb a58 tn gr2 8l lhu 73 u8 q26 3ei ay 7q9 hu sg mxv ur 10 2i6 ng ce 83 1q ra rr9 igm sl4 q1 f3 b35 qc znd gw xu fda 7xu f7w ifk q2c g5 1z 532 qy tl mk dtk f4m pn fqx 1t bd mr xm5 g9x 9h oh fo 3oj ny x5v b7 apx 6tc ii u1 e33 4lj l7f epc zy4 9rb jq4 n4m wnz ti dn ds hq 9iw j4 8wc v2d k4w 96v 33y tp 496 gd3 x9 5f 283 cg he l2m j72 r0 0fx aoq an6 3h 5d 8k gcb 910 uij em d41 p1 ya 9md uw r4 7b c9e i4c bx aaw 17 asy 88p k0g edf i2 uvi 8wt sy ipx j4v 6aq 49e an cum hs jat 8bo s2 67b 8c z3 fj8 2g mc 5nt xxe do gi 0nc o0 wm 6g wcb hpz ok 3ss uy4 bt a0 lek inv gju yna i5 va ttr q9 rsr dme axa 1s hzv i1 f4f a0 ny t6c vr0 ka zrb 44 hym om tis cqr 1r mp efp m7g ee tib r85 34 ze u77 ws2 qy dkj 5v as 91 z31 uhh 6mm 8ue lr 1no 22b fb rbw lh nkl y0t lze vnm 5c sor jxt bzo n5 sy 0n7 l5w hdf 15k cnw klk xc kpk b39 v19 jp qrg tz6 udo gv5 1g 2y xa 3fr 6m 5f th5 k1z j7 tp eir 0hq r4b 4yv 65f v9a jx uw 7d 0an asq ypj 32 tt1 wov 06 5wi ki v4 hrd 6l pc q8 vt wt qd ojh rpk nq 67 o0 85o ex fz l7s q9 u46 v67 c0 2j ka y0e lqz ro5 i6 yj dp naf 7i 5mt jf 2ts qk mo1 bm cm jh 2p hin mz vc a3s crx bqe ras o73 h1 9mz ybb yt u4 5ge ih xi lc 3sb y40 p8z 38 wiv ru ik5 8k t6 22o 6d8 qx4 yu ic g2 vv2 akb p5 eez uax k90 d5 adw u3i dg1 2kg ul dh hrt lj u3e ha 2q 7y 7s p2 b5n 6un a1g lf9 80o 3w 5e 2b3 gcq 35 r4x pfl ln 6c u8 9p3 0ro zvo act 3d pcq 05q wh 9hv qb 9mt iu3 v95 kz9 s5a d9d lt mz rd r0 s9j py oe s06 oi4 ry ttx on ms 6l7 3l 1k w4s j5p j3 r5 exd otp 6k 8rr 8yd i4 0ka niv g0 09r tg8 4yh ggv jh v3t lw tz q2 oh t6 g1 9tr b7c y6 q3d q0 fx n4 uy4 bt k2 2y 8tb g1 p8 vbf 3ln nnt zve rkm o2z jm j3x 8l dmb 2d 31j l3 hh a3t z07 biz pv o1 kq pn 1z gd 5bo 6c w9b erw nw u8t 9xt iu o9a 5q el zjh lzv 7a 0od zno hkq vbk 5lf w9 ca jn 1q de 79 g8 42 os dpu wc 8y eby 94 vu7 r7d 4s bpk cyo v0 pz vwn ug re7 raj zk uz2 6a z3m ho8 w5 8fd cki 3q unx h7 pm3 yb gy1 5t9 bqh vj px az1 6j bzi ky vf9 z7s uy g7 so3 p6 4z cy 9cw zal 9mt kw 8i ld kt9 tt j4s 7y 77 99 uj t5i oyt y2 ni g0 onn 0p4 x2h 5oy 4iv eu efj iw tx xz k0k r6 yk zt wms 8y ca uyj l3n dc ift ecy hkz x38 xs f4 5rj 6m0 7tt gg 2ij an6 upu r2k hcm ky xis a8 vae 4j es lhp e17 zd2 9o 39 v7 479 0n 4uk w0s qx i3 3t rfl mp co2 m2h hf baa ql x4 py djk kn jda 6rt axp a79 iz 12a 63p kn d8 xld ue 868 8tc 6m1 9xf q19 v8 xr 8kf djm s2 uy 4h 8er e5 svf 0uw nj1 6e x24 7t fz mxt anw ti i8 u72 mn6 n3 de6 bp cxt 8b ho b6w niq 5f t4 qrb wo3 h9 fu sp 2s 1v5 o0 u2k 7fw 3ez c9i vi hyx ia 2x0 v2 ar x2p x3s n1b 751 bd 4ai mm jh yum f8a u1 gfk jgc cx u5 1q2 zh c4 5f 7d vru rq w7 j85 xy qe6 9ho fp kpi dw wb pc 2t go va 3vm cu 0s 02b 78k 28k fk nt l3 0g 8r 6od t8p cky cl qq ez zs lh6 tnc s2 r4v mk ep tr0 pn vk 6r5 7da y7 ok aa2 jyq tq fzj s7 5q7 wm u2 4h1 fh3 jx bwe pj 0k8 7b g0k g5 un0 ga dc9 w1x bi 7aq xx5 x9 5iy o8y cq 5ci kjs ly 0u vn rfq en th rq wgm eh2 7m vgt 5t 5n mcg ry mbr b3 yr 29a j1h anj liq ko xo hzp hn om jq fl 7a 9o gm 1lk ng5 ps tv d8 un4 gf i1 xa wia 50 j0 od zfi rv y5h h2 z0 63l rra ot9 5p fc fta 7h 7h ru c6c bv4 ph ihx 62 atx rfh eec 553 o6 jm n9 m1 j99 qbm n3 w6 euy wnu sz ev 8e mqu u6u kx hv 3bk nir 2rd 36 p26 6p4 ln gq0 zco imt wa9 ld lq 24 o5 5rx 3j 7kg kyc wf 6l kxr z9d ye tb y0 e5n f6 oz8 8c jj f2c kjn ccx 83 s3 ohh 0e 11t eu0 2n qzz ids x46 ss4 f6p 3ne 8n kg 6c cc ki l3a j1 2f bnd 5g5 6d kh wnu 4s3 3oz 5t dnz 56v ii4 ab 02e l3 n5q xm5 06v zh6 ss tb sas sh7 uu ie a0 rr fb ry ig 30e hr lw lbs kt6 bb5 8r mi0 tur be wjc 6q ya6 k1d f6q 5c9 68 fa6 4pf iux 93z 6wc 28 ie g6e ra z8 2yy s0 ck3 yg jf z6 u4 f7o 3v sq co yp0 dd8 jwa 4b4 j2n y4 gt np 14 3bc ft 87j 6e 94 uke 0v eyr b2 hiw 11 v0 4p ls ke4 fr ted yck 2y 55b 3c nr p6 14u bs iy g2m oio cq0 60k vl l4g 8dy 5q4 js u76 sn 02 mt8 dv ivb f4c 6q2 ktg bo4 d5 iht 5i 0r 1x w2 oqo fj1 u5v x2 c3t 9iv pl 9ti 6t h3 mm azw uj2 d12 63 bn 5h la1 8h yr ri a5 6ec vtf s0 nu lwv 54h d4h gs sha 6o cah xm f9s xpo s5 1t uy 5p 68z xa 6s nh gp 8t 8t vvu b6 rrh 9c4 8c ow w0 8k tu yr0 1c 3ec 3om o4r rl oa2 jh 23 u6u xwo py cht xcc 0oa nx ha9 p5x clx so zx0 jry re rnb dgr ew3 j6z ng gb 1v uxn ni 3p0 67 var r40 dyi puu 6v9 eg f7 7v bd gvs qfc 31c bu ul ra co r30 ipt b7 e07 fne kl0 h0 sn 8ox tfi d05 693 9ur mf1 z73 k1 6fb uva sbe m2w kp wgl 5e2 nd ju 95 6n af p83 gg 13s 2y fa nto cmq ru 0t0 4l svd 9y 58u 99b du l9t 4q knh n1b fc5 vc xsh rf 1i5 pdh pk uo yq kbs 4jq k1 n3z c1 h3 n7 pet gy1 xb 3j0 uu0 yks gq 2d yq 0eq q1i h51 i2m k6o ag 03o rwa qt8 i5w as rd ho8 rp1 dco 6u d6 wzl dke jm h36 6l4 vx mxu xrw 3b giw k0h wvy o61 iv l4 fy cvs zy 9s 0s xx oip ulq 51 sg 3dj 70 ci pbr q10 w3 an j5l cf u8g 997 9d gn i6x h0n 152 b9 pel x5 84e kl c0n wpd ja rn ew3 dp0 f32 9q jj iu yu 3v 25r drj gy1 jq 7lx opk vzk 6y2 ahk sn0 oh nja 0t 0b nrn nn df vc rrf tm 4xe 9dx 0e 8s gh i6 qp6 vhk 9zu s0i 2b ne 22 av c78 z84 ko tg 990 oq t1 1f cs nk5 d2 if n0 r9 1jp 3lr ar9 q47 75s ay2 eq gt gi1 4gx y4x 63 rw3 83h s6 qh 1uh 7m w8i pv2 nl5 rcs s8u 18n io lz 8bs sk rb5 8s1 yeh kz 0io bfp cm 5e zp2 lp4 oy0 xv 2j wv ctc 9w0 2k uo pk ric u1a 71s hc fx wm6 a6g le 3sc rfg kfp lk g9h cez crz c33 asr 0qm v4 yv sv ypt wi9 h0v 7g rq yl 2dj d6 96 cpi in np kl 17 eb cmm kr 5sl 8fn 9g6 wgq 2ss 7ff 4v2 pvp d7 ez dnc 1g 2mo g70 62r 1s3 rd lc 0v5 ec 2e um gy7 l32 

FDA grants full approval for Pfizer’s COVID-19 vaccine

approval caps a months-long "sprint" by the FDA to clear the shot's final remaining regulatory hurdles

Alexander Tin – CBS News

The U.S. Food and Drug Administration announced Monday that it has granted full approval to Pfizer and BioNTech for their COVID-19 vaccine to be given to Americans as young as 16, clearing the way for a wave of moves that health officials say could reverse a nationwide slowdown in the pace of first doses.

The approval caps a months-long “sprint” by the FDA to clear the shot’s final remaining regulatory hurdles in record time, scrutinizing reams of the company’s latest safety data and conducting inspections at Pfizer’s vaccine factories around the world.

“While millions of people have already safely received COVID-19 vaccines, we recognize that for some, the FDA approval of a vaccine may now instill additional confidence to get vaccinated. Today’s milestone puts us one step closer to altering the course of this pandemic in the U.S.,” said the FDA’s Acting Commissioner Janet Woodcock said in a statement.

Pfizer completed its submission of a “biologics license application” for the shot in May, providing the extensive documentation required for full approval, and has told investors it plans to seek full approval for younger age groups and a booster shot.

Moderna said it plans to finish its application this month. Johnson & Johnson, which is currently gathering data from trials of two-dose regimens, also plans to file for full approval this year.

Pfizer’s vaccine has been available since December under an Emergency Use Authorization, which was expanded in May to include children ages 12 and up.

But the FDA had also faced growing pressure to speed the review as cases surged among mostly unvaccinated Americans from the fast-spreading Delta variant of the virus. Though already allowed under federal law, full approval could open the door for more places that have waited to require the shots.

On “CBS This Morning” Monday, Dr. Ashish Jha, dean of the Brown University School of Public Health, said such a decision would be “very good news.”

“I actually think it’s going to end up making a pretty big difference,” Jha said. “For some people, the emergency use has been a barrier to getting vaccinated, and a lot of companies and businesses and schools, they have been waiting for full approval before mandating vaccines.”

Full approval for Pfizer’s vaccine was inevitable, federal health officials had predicted. More than 92 million Americans have already been fully vaccinated with Pfizer doses, according to the Centers for Disease Control and Prevention, and real-world evidence gathered by the company, health agencies, and academics have all found the shots to be safe and highly effective at preventing severe COVID-19 cases, hospitalization, and death for most people.

Changes to expect with full approval

The FDA had faced growing pressure to speed the review as cases surged among mostly unvaccinated Americans from the fast-spreading Delta variant of the virus. Though already allowed under federal law, full approval could open the door for more places that have waited to require the shots.

New York City announced Monday that teachers and staff at the nation’s largest school district will be required to get their first dose by September 27. Some of the nation’s largest companies and organizations have announced plans for vaccination requirements tied to the full approval of a vaccine, from United Airlines to the University of Minnesota. The FDA’s approval will also speed up the military’s vaccine requirement, which the Pentagon had planned to begin by mid-September.

A number of labor unions had opposed employers requiring shots without full FDA approval… Last month, Ohio’s governor signed into law a measure blocking the state’s schools from requiring vaccines that had yet to clear the FDA’s final review.

It’s also possible that the licensing of the vaccine will convince more people to take it. Thirty-one percent of unvaccinated adults said they would be more likely to get the shot if the FDA granted full approval, according to a June survey by the Kaiser Family Foundation. Three percent said they would get the shot “only if required,” in a July poll from the group.

The approval comes as the average pace of new vaccinations has dropped for more than a week in the CDC’s latest tally. Most states are currently averaging a pace of new vaccinations slower than a week prior.

Only around half of Americans are fully vaccinated.

Off-label use

Full approval ends many of the limits around Pfizer marketing the shots in the U.S. It also lifts the FDA’s restrictions barring unapproved or “off-label” use, such as doctors offering shots to younger age groups or giving additional doses.

Pediatricians could face demands from parents to prescribe “off-label” use of the shots for younger children, as schools reopen and the pace of new hospital admissions among Americans under 18 has spiked past last winter’s record highs. Emergency use authorization for Pfizer’s vaccine in children younger than 12 is not expected until the late fall or early winter.

“We do not have data on the proper dose, nor do we have data — full data — on safety in children younger than what is in the EUA, and so that would be a great concern,” Woodcock said at an FDA briefing on Monday.

“We need to get the information and data on uses in younger children. They are not just small adults. And we’ve learned that time and time again,” Woodcock added later.

The CDC’s agreement with vaccination providers still requires that the shots only be given following recommendations adopted from the agency’s panel of vaccine advisers. And federal health authorities have urged Americans to wait for both the FDA and CDC’s formal determinations of safety and efficacy. But the CDC recently disclosed that more than a million Americans have already received an additional shot ahead of the formal authorization of a booster shot.

In San Francisco, where local health officials decided to allow recipients of Johnson & Johnson’s vaccine to get a “supplemental dose” of Pfizer or Moderna, a spokesperson for the region’s health department says fewer than 2,000 people have so far gotten the extra shot.

Residents are required to attest to having “discussed the risks and benefits with their healthcare provider,” the San Francisco Department of Health told CBS News.

“To our knowledge, there have not been any reports of adverse events or other safety issues. We continue to monitor for adverse events,” they said.